$15 million capital raising enough to fund trials for over two years. [ + ]

Contamination and how scientists can help to clean up will be a focus at CleanUp 09, an international summit being hosted by CRC CARE.

At the intersection of biology and chemistry is where Mark von Itzstein focuses his attention, constantly looking for ways to stay one step in front of diseases like influenza. [ + ]

Professor John Prins has been appointed as CEO and Institute Director at the Mater Medical Research Institute.

A technique for stabilising enzymes could lead to better biosensors, disease therapeutics and diagnostic reagents and non-laboratory applications, including environmental remediation.

The University of Western Australia is considering its options following a judgement from the Full Bench of the Federal Court relating to the University’s right to protect its investment in intellectual property developed by its staff.

Pfizer will pay a total of US$2.3 billion to settle fraud claims resulting from its past promotional practices.

Five year research alliance between CSIRO and Centrelink to improve service delivery. [ + ]

New National Health and Medical Research Council appointed for 2009-2012 term. [ + ]

FDA gives clearance for Phase IIb trial of CVac vaccine in the US. [ + ]

A research alliance between Centrelink and CSIRO will focus on the human services ecosystem, place-based services and technologies for human service delivery. Using statistics and trend analysis techniques the researchers will help to improve service delivery by the Australian Government.

Beckman Coulter has combined Agencourt Bioscience and the newly acquired Cogenics to create Beckman Coulter Genomic.

Completion of phase I clinical trial recruitment for Live Attenuated Influenza Vaccine technology. [ + ]

Gains made through increased sales and currency movements. [ + ]

Sonic, Sirtex, Blackmores, Healthscope, Cellestis [ + ]